Onkologikoa

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Melanoma4 trials
• Liver and biliary tract cancer1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed2 trials
• Terminated2 trials
• Active, not recruiting1 trial

Lead sponsor

• Agenus Inc.1 trial
• Amgen1 trial
• Grupo Español Multidisciplinar de Melanoma1 trial
• Pfizer1 trial
• Taiho Oncology, Inc.1 trial

Running trials

• Active, not recruiting

  Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

  NCT03605771· Grupo Español Multidisciplinar de Melanoma· Source

Closed trials

• Terminated

  A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

  NCT05529316· Phase 2· Agenus Inc.· Source

• Terminated

  Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

  NCT04093362· Phase 3· Taiho Oncology, Inc.· Source

• Completed

  Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

  NCT04068181· Phase 2· Amgen· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Pfizer· Source